Abstract 4986
Background
Different clinicopathological factors have been associated with survival after liver metastasis resection in metastatic colorectal cancer (mCRC) patients. However, there is a need to better identify those patients who may benefit from metastasis resection. In this retrospective study we aimed to analyse clinical outcomes according to KRAS mutational status in a prospective collected series of mCRC patients.
Methods
We evaluated mCRC patients with exon 2 KRAS mutational status assessed between 2010 and 2014. Exon 2 KRAS mutational analysis was performed by therascreen® or cobas® assays. We excluded patients (pts) with no clinical data available. Disease-free survival (DFS) and overall survival (OS) were calculated using the Kaplan-Meier method.
Results
KRAS mutational status was assessed in 395 mCRC patients, but clinical data were only available in 348 patients. Median age was 66 years old. Two hundred and twenty-six patients were male (65%) and 210 pts (60%) had synchronous metastases at diagnosis. KRAS mutations were detected in 175 tumours (51%). Liver was the most common site of metastasis (210 pts, 60%), followed by lung (133 pts, 33%), lymph nodes (56 pts, 16%) and peritoneum (44 pts, 11%). Lung metastases at diagnosis were more frequent in KRAS mutant tumours (38% vs 27%, p-value = 0.022). We observed different metastasis spread pattern between pts with KRAS mutant and KRAS wt tumours. Risk of lung metastasis after 50 months of follow-up was higher in KRAS mutant tumours (77% vs 60%, p=.023). Risk of brain metastasis was also higher (18% vs 2%, p=.012). Median OS was 37 months, with no differences observed between KRAS mutant and KRAS wt tumours (34 vs 41 months, p-value = .70). One hundred thirty-nine patients underwent metastases resection (39.9%). In this subgroup of patients, KRAS mutations were associated with worse DFS (13.3 vs 24.5 months, p-value=.024).
Conclusions
KRAS mutations were associated with lung metastasis in CRC patients and different pattern spread. Although KRAS mutations were not a prognostic biomarker in the metastatic setting, patients with KRAS mutant tumours had a shorter DFS after metastasis resection.
Clinical trial identification
Legal entity responsible for the study
Catalan Institute of Oncology.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract